Long-term effect of lovastatin alone and in combination with cholestyramine on lipoprotein (a) level in familial hypercholesterolemic subjects

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

1972 • 31,801 citations

Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats

2015 • 5,802 citations

A Receptor-Mediated Pathway for Cholesterol Homeostasis

1986 • 5,638 citations

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1987 • 1,842 citations

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

1980 • 1,607 citations

A NEW SERUM TYPE SYSTEM IN MAN—THE L_p SYSTEM

1963 • 1,292 citations

The Mysteries Of Lipoprotein(a)

1989 • 1,247 citations

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

1987 • 884 citations

Lp(a) Lipoprotein as a Risk Factor for Myocardial Infarction

1986 • 779 citations

Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial Hypercholesterolemia

1990 • 591 citations

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

1983 • 562 citations

Human plasma lipoprotein [a]. Structural properties.

1983 • 448 citations

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

1989 • 448 citations

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

1987 • 411 citations

Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism

1980 • 357 citations

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

1989 • 336 citations

Lp(a) lipoprotein and pre‐β₁‐lipoprotein in patients with coronary heart disease

1974 • 308 citations

Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins.

1984 • 282 citations

Protein composition of Lp(a) lipoprotein from human plasma

1983 • 250 citations

Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis.

1989 • 239 citations

Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a)

1985 • 231 citations

Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.

1983 • 211 citations

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

1990 • 203 citations

Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a)

1982 • 150 citations

A New Serum Type System in Man — The Ld System

1965 • 149 citations

Treatment of Primary Moderate Hypercholesterolemia With Lovastatin (Mevinolin) and Colestipol

1987 • 109 citations

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor

1988 • 109 citations

Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects

1991 • 104 citations

Binding of LP(a) to the low density lipoprotein receptor of human fibroblasts

1981 • 103 citations

Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor

1981 • 89 citations

Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia

1988 • 69 citations

Smoking and diet intervention in healthy coronary high risk men. Methods and 5-year follow-up of risk factors in a randomized trial. The Oslo study.

1980 • 34 citations

Drug therapy of hypercholesterolemia.

1988 • 26 citations

Ten commercial kits compared for assay of thyrotropin in the normal and thyrotoxic range.

1988 • 23 citations

Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up

1990 • 16 citations